|
Sumentheran N. Govender is the clinical trials manager for the Population Council's microbicides program. He coordinates the operations of the Carraguard® Phase 3 trial in South Africa. His research interests include HIV and pregnancy, pre-eclampsia, and contraceptive studies. Prior to joining the Council, Govender worked in the department of obstetrics and gynaecology at the Nelson R. Mandela School of Medicine as a project manager for the HIV Prevention Trials Network. He also conducted studies involving pre-eclampsia and menstrual dysfunction among female athletes.
Govender has published articles and given presentations at conferences and workshops around the world. He received both a master's degree and Ph.D. from the Mandela School of Medicine.
A partial list of his publications includes:
Skoler, Stephanie, Sumen N. Govender, Lydia Altini, Khatija Ahmed, Donald Waldron, Landon Myer, and Pekka Lähteenmäki. 2005. "Risks in the use of an unblinded-control group (letter)," Journal of Infectious Diseases 191(8): 1378 1379.
Govender, Sumentheran N., T. Doorsamy, and J. Moodley. 2003. "Maternal neutrophil apoptosis in pre-eclampsia," Journal of Obstetrics and Gynaecology 23(1): 41 43.
Mars, Maurice, Sumentheran N. Govender, Adelle R. Weston, V. Naicker, and A. Chuturgoon. 1998. "High intensity exercise: A cause of lymphocyte apoptosis?" Biochemistry and Biophysics Research Communications 24(2): 366 370. | 